Back to Journals » Patient Preference and Adherence » Volume 13

Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study

Authors Tomaszewski KJ, Allen A, Mocarski M, Schiffman A, Kruger D, Handelsman Y, Heile M, Brod M

Received 14 November 2018

Accepted for publication 10 April 2019

Published 10 May 2019 Volume 2019:13 Pages 761—773

DOI https://doi.org/10.2147/PPA.S194598

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 2

Editor who approved publication: Dr Johnny Chen


Kenneth J Tomaszewski,1 Amy Allen,1 Michelle Mocarski,2 Alisa Schiffman,2 Davida Kruger,3 Yehuda Handelsman,4 Michael Heile,5 Meryl Brod6

1KJT Group, Inc., Honeoye Falls, NY, USA; 2Novo Nordisk Inc., Plainsboro, NJ, USA; 3Henry Ford Health System, Detroit, MI, USA; 4Metabolic Institute of America, Tarzana, CA, USA; 5TriHealth, Cincinnati, OH, USA; 6The Brod Group, Mill Valley, CA, USA

Background: Approximately 60% of the patients with type 2 diabetes mellitus (T2DM) on basal insulin have an HbA1c ≥7%. This analysis of the US Perceptions of Control (POC-US) study aimed to understand US patient and health care professional (HCP) views of diabetes “control,” which may play a role in whether patients reduce their HbA1c or achieve HbA1c <7%.
Methods: A cross-sectional, Web-based survey of 500 US HCPs (primary care physicians, endocrinologists, nurse practitioners/physician assistants) and 618 US adults with T2DM using basal insulin was conducted to assess perceptions, attitudes, and behaviors associated with T2DM management. The survey was developed from previous research examples and qualitative exploratory research and was pretested. Patients self-reported their most recent HbA1c level and confirmed this value with their HCP, if necessary.
Results: Patients and HCPs differed on some definitions of “in control.” HbA1c value was used most often by both populations, but more frequently by HCPs (91% vs 69%). Patients also often used behavioral criteria (eg, adherence to lifestyle changes and/or treatment regimens), and HCPs often used clinical criteria (eg, hypoglycemia). Most HCPs focused on the last 3 months to define control (67% vs 34% patients; P<0.05), whereas patients more frequently reported focusing on “the current moment” or “the past week.” Patients were more likely to agree that controlling their condition is “completely the patients’ responsibility” (patients, 67%; HCPs, 34%; P<0.05); HCPs were more likely to agree that they have “a responsibility to actively contribute to the control of their patients’ T2DM” (90% vs 60%; P<0.05).
Conclusion: US patients with T2DM have differing views from HCPs on key aspects of diabetes control and management and are less likely to consider HbA1c value as a criterion for determining control. Recognizing and addressing these differences may improve patient-HCP communication and may potentially improve patient outcomes.

Keywords: Diabetes control, diabetes management, diabetes perceptions


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]